Innate Pharma S.A (IPH) | Stock Price History & Returns | 2006 - 2026

How has Innate Pharma S.A (IPH) stock performed during last 12 months?

Over the last 12 months, Innate Pharma S.A has delivered a total return of 46.4%.

• 52-Week High reached EUR2.20 on N/A.
• 52-Week Low touched EUR1.03 on N/A.
• Current Price trading at EUR1.54 as of June 4, 2026.

What is Innate Pharma S.A's (IPH) total stock return over the past 5 years?

Over the past 5 years, investing EUR10,000.00 in Innate Pharma S.A (iph) would have grown to approximately EUR14,636.00 as of June 4, 2026, representing a total return of 46.4%.

This represents a compound annual growth rate (CAGR) of 7.9% over the 5-year period.

How does Innate Pharma S.A's Stock 10-year annualized return compare to the Healthcare sector?

Innate Pharma S.A (iph) has delivered an annualized return of 3.9% over the past 10 years.

To illustrate: EUR10,000.00 invested in Innate Pharma S.A would have grown to EUR14,636.00 over this 10-year period.

This performance should be compared against other companies in the Healthcare sector to understand relative performance.

What was Innate Pharma S.A's best-performing year historically?

Innate Pharma S.A (iph) has achieved its strongest performance over the 12 months period, delivering a total return of 46.4%.

What is the longest period of consecutive yearly growth Innate Pharma S.A has achieved historically?

Innate Pharma S.A (iph) shows the following performance across different time periods:

Positive Returns: 12 months (+46.4%), 3 years (+46.4%), 5 years (+46.4%), 10 years (+46.4%)

This represents strong consistency in delivering positive returns across different time horizons.

For more common questions about our data, please visit our About Data page.